chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, Decreased appetite, Diarrhoea, Dyspnoea
Clinical narrative: CHIEF COMPLAINT:   PT states having increased congestion and blood in stool over the last week.  poor appietite.  and diarrhea   HISTORY OF PRESENT ILLNESS:     88 years old male with past medical history of BPH, hypertension, hyperlipidemia, atrial fibrillation, atopic dermatitis, chronic kidney disease, patient presents to the ER complaining of excessive weakness, shortness of breath, COVID-19 screening was positive in the ER.  Patient admits to cough productive of clear sputum, he denies fever, admits poor appetite.  Patient denies chest pain, no lightheadedness or dizziness.
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: Haematochezia, Productive cough, Respiratory tract congestion, SARS-CoV-2 test positive
Clinical narrative: CHIEF COMPLAINT:   PT states having increased congestion and blood in stool over the last week.  poor appietite.  and diarrhea   HISTORY OF PRESENT ILLNESS:     88 years old male with past medical history of BPH, hypertension, hyperlipidemia, atrial fibrillation, atopic dermatitis, chronic kidney disease, patient presents to the ER complaining of excessive weakness, shortness of breath, COVID-19 screening was positive in the ER.  Patient admits to cough productive of clear sputum, he denies fever, admits poor appetite.  Patient denies chest pain, no lightheadedness or dizziness.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Decreased appetite, Diarrhoea, Myalgia, Palpitations, Pyrexia
Clinical narrative: Symptoms onset during the night of vaccination. High fever, shakiness, difficulty controlling urination, diarrhea, muscle aches all over, heart palpitations, loss of appetite for 3-4 days. Recovered after about a week.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Tremor, Urinary incontinence
Clinical narrative: Symptoms onset during the night of vaccination. High fever, shakiness, difficulty controlling urination, diarrhea, muscle aches all over, heart palpitations, loss of appetite for 3-4 days. Recovered after about a week.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Pt. states that after receiving the 3rd Booster of Pfizer 11/05/2021, started experiencing symptoms 11/10/2021 of developing shingles. Primary visit 11/2021, prescribed Valtrex and Trecento Cream for confirmed Shingles.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Computerised tomogram, Disorientation, Face injury, Fatigue
Clinical narrative: Felt fine after shot, major muscle aches when I went to bed, woke up unwell at 7:00 am.  Passed out in bathroom (syncope), hit face on floor (split chin).  Woke up disoriented.  Spouse tried to help me to bed, but passed out again in his arms (syncope).  Woke up to paramedics' questions.  Very disoriented.  Went to  ER by ambulance.  Blood work and CT Scan normal (except thinning bone in right ear).  Slept almost continuously, even through testing, couldn't really open eyes.  Arrived home about 1:00 pm, and slept until about 5:00 pm.  Slept through the night, but still very tired today (Monday).
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Loss of consciousness, Malaise, Myalgia
Clinical narrative: Felt fine after shot, major muscle aches when I went to bed, woke up unwell at 7:00 am.  Passed out in bathroom (syncope), hit face on floor (split chin).  Woke up disoriented.  Spouse tried to help me to bed, but passed out again in his arms (syncope).  Woke up to paramedics' questions.  Very disoriented.  Went to  ER by ambulance.  Blood work and CT Scan normal (except thinning bone in right ear).  Slept almost continuously, even through testing, couldn't really open eyes.  Arrived home about 1:00 pm, and slept until about 5:00 pm.  Slept through the night, but still very tired today (Monday).
Age: 95.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: COVID
Age: 67.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Acute kidney injury, Anaemia, Blood creatinine increased, Blood sodium decreased, Blood urea increased
Clinical narrative: Hospitalized 11/17/2021; COVID-19 positive 11/17/2021; fully vaccinated plus booster  BRIEF OVERVIEW: Discharge Provider: MD Primary Care Provider: MD Admission Date: 11/17/2021 Discharge Date: 11/22/2021 Presenting Problem: Acute kidney injury DETAILS OF HOSPITAL STAY: HOSPITAL COURSE: Patient is a 68 y.o. male with past medical history of OHT 7/9/2021, CKD3, HTN who presents with AKI, cough, diarrhea, fatigue, fevers and chills. Patient had diarrhea 11/11-11/12 but resolved 11/13. Had done CMV testing and stool samples as outpt without any findings. Felt ok 11/15 and went to cardiac rehab. Then 11/16 patient developed cough, fevers and chills and had recurrent diarrhea. He was directed to the ED for further evaluation. Labs revealed Na 129, Cr 4.8 (baseline around 2.9-3 recently), BUN 73, procal 0.31, WBC 3.95, Hgb 7.9, tac level 4.4 on 11/5. Patient found to be COVID19+. CXR suggestive of right middle lobe pneumonia. Patient remains comfortable on room air.   Recent admission 10/4-10/9/21 due to AKI on CKD and mild leukopenia. After initial evaluation, his hypovolemic hyponatremia was felt to be the result of CNI nephrotoxicity with sodium and volume completion. Most recent RHC revealed hypovolemia, so he was liberalized to 3L/2g diet, to which he has been strictly adherent and still remained volume depleted. Nephrology consulted and the patient's sodium level and renal function improved with gentle hydration with NS.  Urine studies were collected to include 24 hour protein. With concern for CNI toxicity, his tacro goal and dose were decreased and everolimus was added with new goals of Tacro 3-5 and Evero 5-7. Due to being hypovolemic and hyponatremic, his home PRN lasix was discontinued upon discharge.  Discharge weight 77.2kg during this prior hospitalization.  For his COVID pneumonia, he was treated with monoclonal antibody, but do not require Decadron steroids.  He is also treated for concurrent community-acquired pneumonia completing 3 days of azithromycin 5 days of IV ceftriaxone.  He had lab findings significant for leukopenia, anemia, and AKI.  He required 2 units of blood transfusion on 11/21.  Stool sample for hemoccult blood pending.  Hematology was consulted for leukopenia and anemia.  Nephrology was consulted who made medication adjustments. Nephrology will plan to see as outpatient.  Patient was continued on tac and goal 2-4 with tac level 6.6 on day of discharge. Everolimus was resumed at discharge and goal 4-6. Patient as placed on atovaquone given AKI during hospitalization and changed back to bactrim at discharge with improving kidney function and the high cost of atovaquone.  Patient seen by me on day of discharge and felt safe for discharge home. Patient and Dr. in agreement.
Age: 67.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, COVID-19 pneumonia, Catheterisation cardiac abnormal, Chest X-ray abnormal, Chills
Clinical narrative: Hospitalized 11/17/2021; COVID-19 positive 11/17/2021; fully vaccinated plus booster  BRIEF OVERVIEW: Discharge Provider: MD Primary Care Provider: MD Admission Date: 11/17/2021 Discharge Date: 11/22/2021 Presenting Problem: Acute kidney injury DETAILS OF HOSPITAL STAY: HOSPITAL COURSE: Patient is a 68 y.o. male with past medical history of OHT 7/9/2021, CKD3, HTN who presents with AKI, cough, diarrhea, fatigue, fevers and chills. Patient had diarrhea 11/11-11/12 but resolved 11/13. Had done CMV testing and stool samples as outpt without any findings. Felt ok 11/15 and went to cardiac rehab. Then 11/16 patient developed cough, fevers and chills and had recurrent diarrhea. He was directed to the ED for further evaluation. Labs revealed Na 129, Cr 4.8 (baseline around 2.9-3 recently), BUN 73, procal 0.31, WBC 3.95, Hgb 7.9, tac level 4.4 on 11/5. Patient found to be COVID19+. CXR suggestive of right middle lobe pneumonia. Patient remains comfortable on room air.   Recent admission 10/4-10/9/21 due to AKI on CKD and mild leukopenia. After initial evaluation, his hypovolemic hyponatremia was felt to be the result of CNI nephrotoxicity with sodium and volume completion. Most recent RHC revealed hypovolemia, so he was liberalized to 3L/2g diet, to which he has been strictly adherent and still remained volume depleted. Nephrology consulted and the patient's sodium level and renal function improved with gentle hydration with NS.  Urine studies were collected to include 24 hour protein. With concern for CNI toxicity, his tacro goal and dose were decreased and everolimus was added with new goals of Tacro 3-5 and Evero 5-7. Due to being hypovolemic and hyponatremic, his home PRN lasix was discontinued upon discharge.  Discharge weight 77.2kg during this prior hospitalization.  For his COVID pneumonia, he was treated with monoclonal antibody, but do not require Decadron steroids.  He is also treated for concurrent community-acquired pneumonia completing 3 days of azithromycin 5 days of IV ceftriaxone.  He had lab findings significant for leukopenia, anemia, and AKI.  He required 2 units of blood transfusion on 11/21.  Stool sample for hemoccult blood pending.  Hematology was consulted for leukopenia and anemia.  Nephrology was consulted who made medication adjustments. Nephrology will plan to see as outpatient.  Patient was continued on tac and goal 2-4 with tac level 6.6 on day of discharge. Everolimus was resumed at discharge and goal 4-6. Patient as placed on atovaquone given AKI during hospitalization and changed back to bactrim at discharge with improving kidney function and the high cost of atovaquone.  Patient seen by me on day of discharge and felt safe for discharge home. Patient and Dr. in agreement.
Age: 67.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Chronic kidney disease, Condition aggravated, Cough, Cytomegalovirus test negative, Diarrhoea
Clinical narrative: Hospitalized 11/17/2021; COVID-19 positive 11/17/2021; fully vaccinated plus booster  BRIEF OVERVIEW: Discharge Provider: MD Primary Care Provider: MD Admission Date: 11/17/2021 Discharge Date: 11/22/2021 Presenting Problem: Acute kidney injury DETAILS OF HOSPITAL STAY: HOSPITAL COURSE: Patient is a 68 y.o. male with past medical history of OHT 7/9/2021, CKD3, HTN who presents with AKI, cough, diarrhea, fatigue, fevers and chills. Patient had diarrhea 11/11-11/12 but resolved 11/13. Had done CMV testing and stool samples as outpt without any findings. Felt ok 11/15 and went to cardiac rehab. Then 11/16 patient developed cough, fevers and chills and had recurrent diarrhea. He was directed to the ED for further evaluation. Labs revealed Na 129, Cr 4.8 (baseline around 2.9-3 recently), BUN 73, procal 0.31, WBC 3.95, Hgb 7.9, tac level 4.4 on 11/5. Patient found to be COVID19+. CXR suggestive of right middle lobe pneumonia. Patient remains comfortable on room air.   Recent admission 10/4-10/9/21 due to AKI on CKD and mild leukopenia. After initial evaluation, his hypovolemic hyponatremia was felt to be the result of CNI nephrotoxicity with sodium and volume completion. Most recent RHC revealed hypovolemia, so he was liberalized to 3L/2g diet, to which he has been strictly adherent and still remained volume depleted. Nephrology consulted and the patient's sodium level and renal function improved with gentle hydration with NS.  Urine studies were collected to include 24 hour protein. With concern for CNI toxicity, his tacro goal and dose were decreased and everolimus was added with new goals of Tacro 3-5 and Evero 5-7. Due to being hypovolemic and hyponatremic, his home PRN lasix was discontinued upon discharge.  Discharge weight 77.2kg during this prior hospitalization.  For his COVID pneumonia, he was treated with monoclonal antibody, but do not require Decadron steroids.  He is also treated for concurrent community-acquired pneumonia completing 3 days of azithromycin 5 days of IV ceftriaxone.  He had lab findings significant for leukopenia, anemia, and AKI.  He required 2 units of blood transfusion on 11/21.  Stool sample for hemoccult blood pending.  Hematology was consulted for leukopenia and anemia.  Nephrology was consulted who made medication adjustments. Nephrology will plan to see as outpatient.  Patient was continued on tac and goal 2-4 with tac level 6.6 on day of discharge. Everolimus was resumed at discharge and goal 4-6. Patient as placed on atovaquone given AKI during hospitalization and changed back to bactrim at discharge with improving kidney function and the high cost of atovaquone.  Patient seen by me on day of discharge and felt safe for discharge home. Patient and Dr. in agreement.
Age: 67.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Drug trough level, Fatigue, Haemoglobin decreased, Hyponatraemia, Hypovolaemia
Clinical narrative: Hospitalized 11/17/2021; COVID-19 positive 11/17/2021; fully vaccinated plus booster  BRIEF OVERVIEW: Discharge Provider: MD Primary Care Provider: MD Admission Date: 11/17/2021 Discharge Date: 11/22/2021 Presenting Problem: Acute kidney injury DETAILS OF HOSPITAL STAY: HOSPITAL COURSE: Patient is a 68 y.o. male with past medical history of OHT 7/9/2021, CKD3, HTN who presents with AKI, cough, diarrhea, fatigue, fevers and chills. Patient had diarrhea 11/11-11/12 but resolved 11/13. Had done CMV testing and stool samples as outpt without any findings. Felt ok 11/15 and went to cardiac rehab. Then 11/16 patient developed cough, fevers and chills and had recurrent diarrhea. He was directed to the ED for further evaluation. Labs revealed Na 129, Cr 4.8 (baseline around 2.9-3 recently), BUN 73, procal 0.31, WBC 3.95, Hgb 7.9, tac level 4.4 on 11/5. Patient found to be COVID19+. CXR suggestive of right middle lobe pneumonia. Patient remains comfortable on room air.   Recent admission 10/4-10/9/21 due to AKI on CKD and mild leukopenia. After initial evaluation, his hypovolemic hyponatremia was felt to be the result of CNI nephrotoxicity with sodium and volume completion. Most recent RHC revealed hypovolemia, so he was liberalized to 3L/2g diet, to which he has been strictly adherent and still remained volume depleted. Nephrology consulted and the patient's sodium level and renal function improved with gentle hydration with NS.  Urine studies were collected to include 24 hour protein. With concern for CNI toxicity, his tacro goal and dose were decreased and everolimus was added with new goals of Tacro 3-5 and Evero 5-7. Due to being hypovolemic and hyponatremic, his home PRN lasix was discontinued upon discharge.  Discharge weight 77.2kg during this prior hospitalization.  For his COVID pneumonia, he was treated with monoclonal antibody, but do not require Decadron steroids.  He is also treated for concurrent community-acquired pneumonia completing 3 days of azithromycin 5 days of IV ceftriaxone.  He had lab findings significant for leukopenia, anemia, and AKI.  He required 2 units of blood transfusion on 11/21.  Stool sample for hemoccult blood pending.  Hematology was consulted for leukopenia and anemia.  Nephrology was consulted who made medication adjustments. Nephrology will plan to see as outpatient.  Patient was continued on tac and goal 2-4 with tac level 6.6 on day of discharge. Everolimus was resumed at discharge and goal 4-6. Patient as placed on atovaquone given AKI during hospitalization and changed back to bactrim at discharge with improving kidney function and the high cost of atovaquone.  Patient seen by me on day of discharge and felt safe for discharge home. Patient and Dr. in agreement.
Age: 67.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Laboratory test abnormal, Leukopenia, Medical diet, Nephropathy toxic, Pneumonia
Clinical narrative: Hospitalized 11/17/2021; COVID-19 positive 11/17/2021; fully vaccinated plus booster  BRIEF OVERVIEW: Discharge Provider: MD Primary Care Provider: MD Admission Date: 11/17/2021 Discharge Date: 11/22/2021 Presenting Problem: Acute kidney injury DETAILS OF HOSPITAL STAY: HOSPITAL COURSE: Patient is a 68 y.o. male with past medical history of OHT 7/9/2021, CKD3, HTN who presents with AKI, cough, diarrhea, fatigue, fevers and chills. Patient had diarrhea 11/11-11/12 but resolved 11/13. Had done CMV testing and stool samples as outpt without any findings. Felt ok 11/15 and went to cardiac rehab. Then 11/16 patient developed cough, fevers and chills and had recurrent diarrhea. He was directed to the ED for further evaluation. Labs revealed Na 129, Cr 4.8 (baseline around 2.9-3 recently), BUN 73, procal 0.31, WBC 3.95, Hgb 7.9, tac level 4.4 on 11/5. Patient found to be COVID19+. CXR suggestive of right middle lobe pneumonia. Patient remains comfortable on room air.   Recent admission 10/4-10/9/21 due to AKI on CKD and mild leukopenia. After initial evaluation, his hypovolemic hyponatremia was felt to be the result of CNI nephrotoxicity with sodium and volume completion. Most recent RHC revealed hypovolemia, so he was liberalized to 3L/2g diet, to which he has been strictly adherent and still remained volume depleted. Nephrology consulted and the patient's sodium level and renal function improved with gentle hydration with NS.  Urine studies were collected to include 24 hour protein. With concern for CNI toxicity, his tacro goal and dose were decreased and everolimus was added with new goals of Tacro 3-5 and Evero 5-7. Due to being hypovolemic and hyponatremic, his home PRN lasix was discontinued upon discharge.  Discharge weight 77.2kg during this prior hospitalization.  For his COVID pneumonia, he was treated with monoclonal antibody, but do not require Decadron steroids.  He is also treated for concurrent community-acquired pneumonia completing 3 days of azithromycin 5 days of IV ceftriaxone.  He had lab findings significant for leukopenia, anemia, and AKI.  He required 2 units of blood transfusion on 11/21.  Stool sample for hemoccult blood pending.  Hematology was consulted for leukopenia and anemia.  Nephrology was consulted who made medication adjustments. Nephrology will plan to see as outpatient.  Patient was continued on tac and goal 2-4 with tac level 6.6 on day of discharge. Everolimus was resumed at discharge and goal 4-6. Patient as placed on atovaquone given AKI during hospitalization and changed back to bactrim at discharge with improving kidney function and the high cost of atovaquone.  Patient seen by me on day of discharge and felt safe for discharge home. Patient and Dr. in agreement.
Age: 67.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Procalcitonin, Protein urine, Pyrexia, Renal impairment, SARS-CoV-2 test positive
Clinical narrative: Hospitalized 11/17/2021; COVID-19 positive 11/17/2021; fully vaccinated plus booster  BRIEF OVERVIEW: Discharge Provider: MD Primary Care Provider: MD Admission Date: 11/17/2021 Discharge Date: 11/22/2021 Presenting Problem: Acute kidney injury DETAILS OF HOSPITAL STAY: HOSPITAL COURSE: Patient is a 68 y.o. male with past medical history of OHT 7/9/2021, CKD3, HTN who presents with AKI, cough, diarrhea, fatigue, fevers and chills. Patient had diarrhea 11/11-11/12 but resolved 11/13. Had done CMV testing and stool samples as outpt without any findings. Felt ok 11/15 and went to cardiac rehab. Then 11/16 patient developed cough, fevers and chills and had recurrent diarrhea. He was directed to the ED for further evaluation. Labs revealed Na 129, Cr 4.8 (baseline around 2.9-3 recently), BUN 73, procal 0.31, WBC 3.95, Hgb 7.9, tac level 4.4 on 11/5. Patient found to be COVID19+. CXR suggestive of right middle lobe pneumonia. Patient remains comfortable on room air.   Recent admission 10/4-10/9/21 due to AKI on CKD and mild leukopenia. After initial evaluation, his hypovolemic hyponatremia was felt to be the result of CNI nephrotoxicity with sodium and volume completion. Most recent RHC revealed hypovolemia, so he was liberalized to 3L/2g diet, to which he has been strictly adherent and still remained volume depleted. Nephrology consulted and the patient's sodium level and renal function improved with gentle hydration with NS.  Urine studies were collected to include 24 hour protein. With concern for CNI toxicity, his tacro goal and dose were decreased and everolimus was added with new goals of Tacro 3-5 and Evero 5-7. Due to being hypovolemic and hyponatremic, his home PRN lasix was discontinued upon discharge.  Discharge weight 77.2kg during this prior hospitalization.  For his COVID pneumonia, he was treated with monoclonal antibody, but do not require Decadron steroids.  He is also treated for concurrent community-acquired pneumonia completing 3 days of azithromycin 5 days of IV ceftriaxone.  He had lab findings significant for leukopenia, anemia, and AKI.  He required 2 units of blood transfusion on 11/21.  Stool sample for hemoccult blood pending.  Hematology was consulted for leukopenia and anemia.  Nephrology was consulted who made medication adjustments. Nephrology will plan to see as outpatient.  Patient was continued on tac and goal 2-4 with tac level 6.6 on day of discharge. Everolimus was resumed at discharge and goal 4-6. Patient as placed on atovaquone given AKI during hospitalization and changed back to bactrim at discharge with improving kidney function and the high cost of atovaquone.  Patient seen by me on day of discharge and felt safe for discharge home. Patient and Dr. in agreement.
Age: 67.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Stool analysis normal, Toxicity to various agents, Transfusion, Urine analysis, White blood cell count decreased
Clinical narrative: Hospitalized 11/17/2021; COVID-19 positive 11/17/2021; fully vaccinated plus booster  BRIEF OVERVIEW: Discharge Provider: MD Primary Care Provider: MD Admission Date: 11/17/2021 Discharge Date: 11/22/2021 Presenting Problem: Acute kidney injury DETAILS OF HOSPITAL STAY: HOSPITAL COURSE: Patient is a 68 y.o. male with past medical history of OHT 7/9/2021, CKD3, HTN who presents with AKI, cough, diarrhea, fatigue, fevers and chills. Patient had diarrhea 11/11-11/12 but resolved 11/13. Had done CMV testing and stool samples as outpt without any findings. Felt ok 11/15 and went to cardiac rehab. Then 11/16 patient developed cough, fevers and chills and had recurrent diarrhea. He was directed to the ED for further evaluation. Labs revealed Na 129, Cr 4.8 (baseline around 2.9-3 recently), BUN 73, procal 0.31, WBC 3.95, Hgb 7.9, tac level 4.4 on 11/5. Patient found to be COVID19+. CXR suggestive of right middle lobe pneumonia. Patient remains comfortable on room air.   Recent admission 10/4-10/9/21 due to AKI on CKD and mild leukopenia. After initial evaluation, his hypovolemic hyponatremia was felt to be the result of CNI nephrotoxicity with sodium and volume completion. Most recent RHC revealed hypovolemia, so he was liberalized to 3L/2g diet, to which he has been strictly adherent and still remained volume depleted. Nephrology consulted and the patient's sodium level and renal function improved with gentle hydration with NS.  Urine studies were collected to include 24 hour protein. With concern for CNI toxicity, his tacro goal and dose were decreased and everolimus was added with new goals of Tacro 3-5 and Evero 5-7. Due to being hypovolemic and hyponatremic, his home PRN lasix was discontinued upon discharge.  Discharge weight 77.2kg during this prior hospitalization.  For his COVID pneumonia, he was treated with monoclonal antibody, but do not require Decadron steroids.  He is also treated for concurrent community-acquired pneumonia completing 3 days of azithromycin 5 days of IV ceftriaxone.  He had lab findings significant for leukopenia, anemia, and AKI.  He required 2 units of blood transfusion on 11/21.  Stool sample for hemoccult blood pending.  Hematology was consulted for leukopenia and anemia.  Nephrology was consulted who made medication adjustments. Nephrology will plan to see as outpatient.  Patient was continued on tac and goal 2-4 with tac level 6.6 on day of discharge. Everolimus was resumed at discharge and goal 4-6. Patient as placed on atovaquone given AKI during hospitalization and changed back to bactrim at discharge with improving kidney function and the high cost of atovaquone.  Patient seen by me on day of discharge and felt safe for discharge home. Patient and Dr. in agreement.
Age: 70.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: COVID
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea
Clinical narrative: Shortness of breath, trouble breathing every day.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Stent placement, Thrombosis
Clinical narrative: Clot to heart with stent subsequently done
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Atrioventricular block second degree, Influenza like illness, Lethargy
Clinical narrative: severe flu symptoms with lethargy for 2 days.  Then development of 2nd degree Heart Block, Type 1 for 72 hours
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain, Lymphadenopathy
Clinical narrative: Swollen lymph nodes that throb with sharp pain from time to time under left armpit, beginning the morning after the shot.  I took aspirin on Saturday, Tylenol Saturday night and Sunday.  It persists until today. Sore arm, beginning from time of the shot to Sunday afternoon.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Muscle spasms
Clinical narrative: Severe chest and back muscle spasms that seized up and would not release, similar in feeling to a "charley horse". The first series of these spasms began the day after vaccination at 5:00 pm and lasted for an hour, and then a second series began around 6:30 pm and also lasted for an hour. I took 400mg of ibuprofen at 5:30 pm with no results. There was no change in heart rate and no feelings of heart spasms. This also happened during my second COVID vaccination with the same timing, but I did not think it was related to the vaccine until it happened during the same time frame this time around. I have not experienced these symptoms at any other time in my life.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Neck pain, Pain in extremity, Tremor
Clinical narrative: Severe tremors during night. First one lasting about 15 minutes. Second one slightly less time.  Pain in right arm, shoulder and neck. Might also have experienced chills.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Bell's palsy, Blood test, Magnetic resonance imaging
Clinical narrative: I was diagnosed with Bell's Palsy
Age: 15.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Pain in extremity, Pyrexia
Clinical narrative: Fever,chills,headache,vomiting,tiredness, sore arm for 6 days
Age: 15.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Fever,chills,headache,vomiting,tiredness, sore arm for 6 days
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Encephalopathy, Pancytopenia, SARS-CoV-2 test positive, Sepsis
Clinical narrative: Patient presented to emergency department on 10/11/2021 with pancytopenia. She was diagnosed with COVID-19 infection at outside facility and did not require treatment for infection during admission. Patient was discharged to skilled nursing facility on 10/15/2021. Patient was readmitted to hospital on 10/20/2021 with acute sepsis and encephalopathy. She was still COVID-19 positive during this admission, but did not require any treatment. She was transferred to hospice services and discharged to home hospice on 11/10/2021.
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: PATIENT RECEIVED VACCINE THAT EXPERIENCED A TEMPERATURE EXCURSION, VACCINE WAS KEPT IN THE REFRIGERATOR FOR MORE THAN 30 DAYS. NO ADVERSE REACTION.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Dyspnoea, Positive airway pressure therapy, SARS-CoV-2 test positive
Clinical narrative: CHIEF COMPLAINT:   pt to ed via ems for shortness of breath pt tested postive for covid on wednesday   HISTORY OF PRESENT ILLNESS:     Patient is a 71-year-old female.  She was positive for Covid on November 23.  She had worsening shortness of breath tonight and therefore she contacted EMS EMS gave her DuoNeb put her on CPAP.  The patient does have COPD and is a smoker.  She was also given dexamethasone by EMS did have improvement.  Here her O2 sat is 96% EMS tells me that it was 80% in the field.  No vomiting no fever no rash.  Was vaccinated as per the note from the primary care provider several months ago with 1 Johnson & Johnson vaccine.  Location as above quality as above severity moderate duration as noted context this occurred at home associated symptoms none modifying factors none.
Age: 9.0
Sex: F
Vaccine: COVID19
Symptoms: Loss of consciousness, Syncope
Clinical narrative: "Pfizer-BioNTech COVID-19 Vaccine EUA" Fainted/lost consciousness for 3-4 seconds after leaving the consultation room and walking through the store.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Eye infection, Eye swelling, Herpes zoster
Clinical narrative: Eye became swollen and became infected. Was diagnosed with Shingles by healthcare provider.
Age: 68.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Petechiae
Clinical narrative: I noticed small red broken capillaries under the skin on both forearms, where I had not bruised the  location.  They just sprung up out of nowhere.  The first ones were about the size of a pencil eraser, then in August one broke out on my  left forearm that was the size of a silver dollar.  I had done nothing to injure my arm(s).  Thrombocytopenia?
Age: 82.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Immunocompromised patient, fully vaccinated with Moderna (2 doses) with breakthrough COVID infection. Patient states she initially tested positive for COVID on 11/16/21. We do not have record of this positive, but presented to our facility on 11/27/21 with worsening symptoms and had a positive lab on 11/27/21.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Amnesia, Aphasia, Blindness, Chest X-ray, Computerised tomogram
Clinical narrative: Stroke-like symptoms began 10 minutes after injection. Vision loss/blurriness, numbness in legs and face, dizziness. Neurological effects have continued on 3 months post-vaccine including memory loss, poor comprehension, slurred speech and unable to put together thoughts into words.  Vision has changed from 20/40 to 20/400 and has not improved since the day receiving the vaccine through the time submitting it. Went from myopia to presbyopia and eyes are crossing.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Dysarthria, Eye exercises, Hypoaesthesia, Magnetic resonance imaging
Clinical narrative: Stroke-like symptoms began 10 minutes after injection. Vision loss/blurriness, numbness in legs and face, dizziness. Neurological effects have continued on 3 months post-vaccine including memory loss, poor comprehension, slurred speech and unable to put together thoughts into words.  Vision has changed from 20/40 to 20/400 and has not improved since the day receiving the vaccine through the time submitting it. Went from myopia to presbyopia and eyes are crossing.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Mental impairment, Myopia, Neurological symptom, Ophthalmological examination, Presbyopia
Clinical narrative: Stroke-like symptoms began 10 minutes after injection. Vision loss/blurriness, numbness in legs and face, dizziness. Neurological effects have continued on 3 months post-vaccine including memory loss, poor comprehension, slurred speech and unable to put together thoughts into words.  Vision has changed from 20/40 to 20/400 and has not improved since the day receiving the vaccine through the time submitting it. Went from myopia to presbyopia and eyes are crossing.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Pulmonary function test, Pupil dilation procedure, Strabismus, Vision blurred
Clinical narrative: Stroke-like symptoms began 10 minutes after injection. Vision loss/blurriness, numbness in legs and face, dizziness. Neurological effects have continued on 3 months post-vaccine including memory loss, poor comprehension, slurred speech and unable to put together thoughts into words.  Vision has changed from 20/40 to 20/400 and has not improved since the day receiving the vaccine through the time submitting it. Went from myopia to presbyopia and eyes are crossing.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary mass, Lymphadenopathy, Pain
Clinical narrative: Painful lump in armpit; swollen lymph node
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Adverse reaction, Arrhythmia, Blood creatine phosphokinase, Blood creatine phosphokinase MB, Blood magnesium
Clinical narrative: 10 minutes after my Pfizer injection, my left arm (which was injected with the vaccine) became numb. I actually began to pinch it because it felt so weird. Next my legs both became numb, followed by my right arm and face. At this point my heart started to beat extremely fast. I do wear an apple watch and checked my heart rate. It was at 184. I checked my pulse myself and it did match up to the tachycardia. At this time, I started to shake. I am assuming because I was scared and flagged down the pharmacist stating I think I am having a reaction. They immediately had me sit back down, got me water, and I removed my mask to start taking deep breaths to calm my heart rate.  The pharmacist got me 50 MG of Benadryl. After I took this, my heart rate ranged from 140-180 for the next 30 minutes. At this time, the numbness and shaking would come and go. I also got extremally cold once my heartrate started to slow down. I left pharmacy after 45 minutes of monitoring with a heart rate of 120. I went home and took a nap to rest. I continued to take 50 MG of Benadryl every 4 hours at this time.. Near the end of the 4 hours, my extremities and face started to tingle. My heart rate remained between 120-130 when walking around my house. At rest it would sit at 100. 12+ hours after my vaccination, I was extremely cold, had palpitations, chest pain, my resting heart rate was tachycardic, my extremities were tingling while taking the Benadryl. My brother in law who is a paramedic came to check on me during the evening. My heart rate was jumping from 140 to 80 to 120 to 140. He noticed an arrythmia. I am 29 with no cardiac history. At this time he recommended I go to the emergency room. At the emergency room the ER physician performed a cardiac workup with lab work, chest x-ray, and 12 lead EKG. He gave me ativan to see if my tachycardia was stress related and 1 bag of fluids. At the end of my visit, he did discharge me home stating that I fall into the 1-2% of patients who experience this type of reaction. It is benign and should resolve withing 24-36 hours. I went home and relaxed for the next 2 days. During these 2 days I continued to experience chest pain, tachycardia, palpitations, and SOB with any exertion or movement. 6 days post vaccination, I followed up with my PCP. At this time I had high blood pressure, tachycardic at 140 BPM, SOB, and severe chest pain. My PCP prescribed me Beta Blockers at this time hoping that in 14 days we could take me off the blockers and my adverse reaction would resolve. Currently, I am taking the Beta Blockers at home while out on medical leave from work.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Chest X-ray, Chest pain, Dyspnoea, Dyspnoea exertional, Electrocardiogram
Clinical narrative: 10 minutes after my Pfizer injection, my left arm (which was injected with the vaccine) became numb. I actually began to pinch it because it felt so weird. Next my legs both became numb, followed by my right arm and face. At this point my heart started to beat extremely fast. I do wear an apple watch and checked my heart rate. It was at 184. I checked my pulse myself and it did match up to the tachycardia. At this time, I started to shake. I am assuming because I was scared and flagged down the pharmacist stating I think I am having a reaction. They immediately had me sit back down, got me water, and I removed my mask to start taking deep breaths to calm my heart rate.  The pharmacist got me 50 MG of Benadryl. After I took this, my heart rate ranged from 140-180 for the next 30 minutes. At this time, the numbness and shaking would come and go. I also got extremally cold once my heartrate started to slow down. I left pharmacy after 45 minutes of monitoring with a heart rate of 120. I went home and took a nap to rest. I continued to take 50 MG of Benadryl every 4 hours at this time.. Near the end of the 4 hours, my extremities and face started to tingle. My heart rate remained between 120-130 when walking around my house. At rest it would sit at 100. 12+ hours after my vaccination, I was extremely cold, had palpitations, chest pain, my resting heart rate was tachycardic, my extremities were tingling while taking the Benadryl. My brother in law who is a paramedic came to check on me during the evening. My heart rate was jumping from 140 to 80 to 120 to 140. He noticed an arrythmia. I am 29 with no cardiac history. At this time he recommended I go to the emergency room. At the emergency room the ER physician performed a cardiac workup with lab work, chest x-ray, and 12 lead EKG. He gave me ativan to see if my tachycardia was stress related and 1 bag of fluids. At the end of my visit, he did discharge me home stating that I fall into the 1-2% of patients who experience this type of reaction. It is benign and should resolve withing 24-36 hours. I went home and relaxed for the next 2 days. During these 2 days I continued to experience chest pain, tachycardia, palpitations, and SOB with any exertion or movement. 6 days post vaccination, I followed up with my PCP. At this time I had high blood pressure, tachycardic at 140 BPM, SOB, and severe chest pain. My PCP prescribed me Beta Blockers at this time hoping that in 14 days we could take me off the blockers and my adverse reaction would resolve. Currently, I am taking the Beta Blockers at home while out on medical leave from work.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling cold, Fibrin D dimer, Full blood count, Heart rate increased, Hypertension
Clinical narrative: 10 minutes after my Pfizer injection, my left arm (which was injected with the vaccine) became numb. I actually began to pinch it because it felt so weird. Next my legs both became numb, followed by my right arm and face. At this point my heart started to beat extremely fast. I do wear an apple watch and checked my heart rate. It was at 184. I checked my pulse myself and it did match up to the tachycardia. At this time, I started to shake. I am assuming because I was scared and flagged down the pharmacist stating I think I am having a reaction. They immediately had me sit back down, got me water, and I removed my mask to start taking deep breaths to calm my heart rate.  The pharmacist got me 50 MG of Benadryl. After I took this, my heart rate ranged from 140-180 for the next 30 minutes. At this time, the numbness and shaking would come and go. I also got extremally cold once my heartrate started to slow down. I left pharmacy after 45 minutes of monitoring with a heart rate of 120. I went home and took a nap to rest. I continued to take 50 MG of Benadryl every 4 hours at this time.. Near the end of the 4 hours, my extremities and face started to tingle. My heart rate remained between 120-130 when walking around my house. At rest it would sit at 100. 12+ hours after my vaccination, I was extremely cold, had palpitations, chest pain, my resting heart rate was tachycardic, my extremities were tingling while taking the Benadryl. My brother in law who is a paramedic came to check on me during the evening. My heart rate was jumping from 140 to 80 to 120 to 140. He noticed an arrythmia. I am 29 with no cardiac history. At this time he recommended I go to the emergency room. At the emergency room the ER physician performed a cardiac workup with lab work, chest x-ray, and 12 lead EKG. He gave me ativan to see if my tachycardia was stress related and 1 bag of fluids. At the end of my visit, he did discharge me home stating that I fall into the 1-2% of patients who experience this type of reaction. It is benign and should resolve withing 24-36 hours. I went home and relaxed for the next 2 days. During these 2 days I continued to experience chest pain, tachycardia, palpitations, and SOB with any exertion or movement. 6 days post vaccination, I followed up with my PCP. At this time I had high blood pressure, tachycardic at 140 BPM, SOB, and severe chest pain. My PCP prescribed me Beta Blockers at this time hoping that in 14 days we could take me off the blockers and my adverse reaction would resolve. Currently, I am taking the Beta Blockers at home while out on medical leave from work.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Impaired work ability, International normalised ratio, Metabolic function test, Palpitations
Clinical narrative: 10 minutes after my Pfizer injection, my left arm (which was injected with the vaccine) became numb. I actually began to pinch it because it felt so weird. Next my legs both became numb, followed by my right arm and face. At this point my heart started to beat extremely fast. I do wear an apple watch and checked my heart rate. It was at 184. I checked my pulse myself and it did match up to the tachycardia. At this time, I started to shake. I am assuming because I was scared and flagged down the pharmacist stating I think I am having a reaction. They immediately had me sit back down, got me water, and I removed my mask to start taking deep breaths to calm my heart rate.  The pharmacist got me 50 MG of Benadryl. After I took this, my heart rate ranged from 140-180 for the next 30 minutes. At this time, the numbness and shaking would come and go. I also got extremally cold once my heartrate started to slow down. I left pharmacy after 45 minutes of monitoring with a heart rate of 120. I went home and took a nap to rest. I continued to take 50 MG of Benadryl every 4 hours at this time.. Near the end of the 4 hours, my extremities and face started to tingle. My heart rate remained between 120-130 when walking around my house. At rest it would sit at 100. 12+ hours after my vaccination, I was extremely cold, had palpitations, chest pain, my resting heart rate was tachycardic, my extremities were tingling while taking the Benadryl. My brother in law who is a paramedic came to check on me during the evening. My heart rate was jumping from 140 to 80 to 120 to 140. He noticed an arrythmia. I am 29 with no cardiac history. At this time he recommended I go to the emergency room. At the emergency room the ER physician performed a cardiac workup with lab work, chest x-ray, and 12 lead EKG. He gave me ativan to see if my tachycardia was stress related and 1 bag of fluids. At the end of my visit, he did discharge me home stating that I fall into the 1-2% of patients who experience this type of reaction. It is benign and should resolve withing 24-36 hours. I went home and relaxed for the next 2 days. During these 2 days I continued to experience chest pain, tachycardia, palpitations, and SOB with any exertion or movement. 6 days post vaccination, I followed up with my PCP. At this time I had high blood pressure, tachycardic at 140 BPM, SOB, and severe chest pain. My PCP prescribed me Beta Blockers at this time hoping that in 14 days we could take me off the blockers and my adverse reaction would resolve. Currently, I am taking the Beta Blockers at home while out on medical leave from work.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia, Pregnancy test, Tachycardia, Tremor, Troponin I
Clinical narrative: 10 minutes after my Pfizer injection, my left arm (which was injected with the vaccine) became numb. I actually began to pinch it because it felt so weird. Next my legs both became numb, followed by my right arm and face. At this point my heart started to beat extremely fast. I do wear an apple watch and checked my heart rate. It was at 184. I checked my pulse myself and it did match up to the tachycardia. At this time, I started to shake. I am assuming because I was scared and flagged down the pharmacist stating I think I am having a reaction. They immediately had me sit back down, got me water, and I removed my mask to start taking deep breaths to calm my heart rate.  The pharmacist got me 50 MG of Benadryl. After I took this, my heart rate ranged from 140-180 for the next 30 minutes. At this time, the numbness and shaking would come and go. I also got extremally cold once my heartrate started to slow down. I left pharmacy after 45 minutes of monitoring with a heart rate of 120. I went home and took a nap to rest. I continued to take 50 MG of Benadryl every 4 hours at this time.. Near the end of the 4 hours, my extremities and face started to tingle. My heart rate remained between 120-130 when walking around my house. At rest it would sit at 100. 12+ hours after my vaccination, I was extremely cold, had palpitations, chest pain, my resting heart rate was tachycardic, my extremities were tingling while taking the Benadryl. My brother in law who is a paramedic came to check on me during the evening. My heart rate was jumping from 140 to 80 to 120 to 140. He noticed an arrythmia. I am 29 with no cardiac history. At this time he recommended I go to the emergency room. At the emergency room the ER physician performed a cardiac workup with lab work, chest x-ray, and 12 lead EKG. He gave me ativan to see if my tachycardia was stress related and 1 bag of fluids. At the end of my visit, he did discharge me home stating that I fall into the 1-2% of patients who experience this type of reaction. It is benign and should resolve withing 24-36 hours. I went home and relaxed for the next 2 days. During these 2 days I continued to experience chest pain, tachycardia, palpitations, and SOB with any exertion or movement. 6 days post vaccination, I followed up with my PCP. At this time I had high blood pressure, tachycardic at 140 BPM, SOB, and severe chest pain. My PCP prescribed me Beta Blockers at this time hoping that in 14 days we could take me off the blockers and my adverse reaction would resolve. Currently, I am taking the Beta Blockers at home while out on medical leave from work.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chills, Extra dose administered, Fatigue, Heart rate increased
Clinical narrative: Pt. states that after receiving the 3rd Booster of Phizer 10/07/2021, started experiencing symptoms that evening of fever, chills, fatigue, weakness, and high Heart Rate (120). Cardiologist visit 11/19/2021 (High Blood-Pressure Follow-Up), advised to Report. No lingering side effects advised.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Hypertension, Pyrexia
Clinical narrative: Pt. states that after receiving the 3rd Booster of Phizer 10/07/2021, started experiencing symptoms that evening of fever, chills, fatigue, weakness, and high Heart Rate (120). Cardiologist visit 11/19/2021 (High Blood-Pressure Follow-Up), advised to Report. No lingering side effects advised.
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Asymptomatic COVID-19, COVID-19, SARS-CoV-2 test positive
Clinical narrative: Vaccinated 4/1/21. Asymptomatic positive during hospitalization 11/27/21.
Age: 40.0
Sex: F
Vaccine: FLU4
Symptoms: Dizziness, Feeling abnormal, Headache, Nasal congestion
Clinical narrative: Headaches, dizziness, stuffy nose. Headaches have come and gone since 10/26/21 and have lingered longer than any other side effect
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Asymptomatic COVID-19, COVID-19, SARS-CoV-2 test positive
Clinical narrative: Patient presented to emergency department on 10/13/2021. She was found to be COVID-19 positive but was asymptomatic during admission. She required no treatment. Her husband was also admitted during this time with COVID-19 who is her primary caregiver. She was brought to hospital for facility placement. She was discharged on 10/20/2021 to an acute rehab facility.